Triveni Bio logo

Director, Biostatistics

Triveni Bio

Watertown, MAOnsitePosted 1 day ago$230,000 - $250,000 a year
Full TimeDirector & AboveBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

Triveni Bio is seeking a Director, Biostatistics to join our expanding Development organization. Reporting into the Exec. Director, Biometrics, you will provide leadership and guidance for early to late immunological and inflammatory clinical trials. You will be responsible for all aspects of statistical activities including designing clinical trials, co-authoring protocols, preparing statistical analysis plans, implementation of statistical analysis, interpreting and communicating the results of clinical trial data, and providing statistical support for other non-clinical and clinical groups.

Job description

Summary

Triveni Bio is seeking a Director, Biostatistics to join our expanding Development organization. Reporting into the Exec. Director, Biometrics, you will provide leadership and guidance for early to late immunological and inflammatory clinical trials. You will be responsible for all aspects of statistical activities including designing clinical trials, co-authoring protocols, preparing statistical analysis plans, implementation of statistical analysis, interpreting and communicating the results of clinical trial data, and providing statistical support for other non-clinical and clinical groups.

Responsibilities

  • Contribute to the development of clinical plans with strategic thinking, lead innovative study designs and statistical activities.
  • Provides statistical guidance and supports to ongoing trials
  • Collaborates with Data Management, Clinical Development, Clinical Pharmacology, Translational Medicine, Clinical Operations, Regulatory, Data Science and other internal stake holders
  • Contributes to clinical study reports and other regulatory documents e.g. DSURs, Briefing Documents, etc.
  • Consults with other Research & Development groups to provide statistical support
  • Interprets and communicates the results of statistical analysis of clinical trial data
  • Oversight of CROs' statistical, statistical programming and data management

Experience & Qualifications

  • Ph.D. in Statistics or Biostatistics or equivalent with at least 8+ years pharmaceutical statistics experience
  • Excellent written and oral communication and presentation skills
  • Experience designing and supporting early to late-phase clinical studies
  • Experience conducting clinical trial simulations to evaluate design options, operating characteristics, and decision criteria
  • Experience with Bayesian and adaptive clinical trial design
  • Proficiency in R programming language
  • Experience interacting with health authorities is a plus

Requirements

  • Ph.D. in Statistics or Biostatistics or equivalent
  • At least 8+ years pharmaceutical statistics experience
  • Excellent written and oral communication and presentation skills
  • Experience designing and supporting early to late-phase clinical studies
  • Experience conducting clinical trial simulations to evaluate design options, operating characteristics, and decision criteria
  • Experience with Bayesian and adaptive clinical trial design
  • Proficiency in R programming language
  • Experience interacting with health authorities is a plus

Benefits

  • Competitive target bonus
  • Equity
  • Comprehensive benefits package

Company overview

Triveni Bio is a clinical-stage biotechnology company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of immunological and inflammatory (I&I) disorders. Founded in 2019 and headquartered in Watertown, Massachusetts, the company leverages advanced antibody engineering to build first-in-class therapeutics that aim to redefine treatment paradigms for complex diseases. Triveni's lead asset, TRIV-509, is a dual-specific monoclonal antibody targeting kallikreins 5 and 7 for the treatment of atopic dermatitis, currently in Phase 2 clinical trials. The company's approach establishes proof-of-concept at the earliest stages of drug development by combining human genetics insights with mechanistic biology to identify novel targets and develop precision medicines. Triveni Bio has raised significant funding, including a $115 million Series B round in 2024, and has been recognized as a Fierce 15 biotech company for its innovative approach to addressing unmet medical needs in dermatology and immunology.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.